IRPSY yields 0.64% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, IRPSY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IRPSY + JNJ for your $10,000?
IRPC Public Company Limited, together with its subsidiaries, provides petroleum and petrochemical products in Thailand, Singapore, and internationally. The company operates through Petroleum Products, Petrochemical Products, and Other Business segments. It offers petroleum products, including liquefied petroleum gas, gasohol, gasoline base, diesel, diesel base, gasoline, fuel oil, lube base oil, slack wax, aromatic extract, treated distillate aromatic extract and residue aromatic extract, asphalt, straight-run fuel oil, white spirit, C9 aromatic/aromatic, toluene, xylene, mixed xylenes; and polyethylene, polypropylene, acrylonitrile-butadiene-styrene, acrylonitrile styrene, polystyrene, expandable polystyrene, and additives. It also generates and distributes electricity, power, steam, industrial water, and air systems; and wastewater treatment services for industrial customers. In addition, the company offers port and tank services, such as tugboats, piloting services, lighters, fresh water and fuel, weigh scales, container yards, warehouses, and machines and equipment for the transshipment of goods. Further, it is involved in the provision of asset management and oil vessel renting services; manufacture and distribution of plastic resins; operation of vocational schools; distribution of non-woven fabric products and medical consumables; and distribution of petrochemical products, as well as power plant, jetty, and other utilities operations. The company was formerly known as Thai Petrochemical Industry Public Company Limited and changed its name to IRPC Public Company Limited in October 2006. IRPC Public Company Limited was incorporated in 1978 and is headquartered in Rayong, Thailand.
Full IRPSY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.